Synvista Therapeutics, Inc. (SYNI)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Aug 14, 2025
Synvista Therapeutics Market Cap
Synvista Therapeutics has a market cap or net worth of $3.00 as of October 7, 2025. Its market cap has decreased by -99.99% in one year.
Market Cap
3.00
Enterprise Value
n/a
Revenue
54.73K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 1, 1991, Synvista Therapeutics's market cap has decreased from 330.80M to 3.00, a decrease of -100.00%. That is a compound annual growth rate of -42.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 3.00 | - |
| Dec 30, 2020 | 3.00 | -88.46% |
| Dec 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 326.79M |
| American Oncology Network | 281.53M |
| Silence Therapeutics | 236.17M |